151 related articles for article (PubMed ID: 29736166)
1. Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study.
Mazzei MA; Bagnacci G; Gentili F; Nigri A; Pelini V; Vindigni C; Mazzei FG; Baiocchi GL; Pittiani F; Morgagni P; Petrella E; Mura G; Verdelli B; Bencivenga M; Giacopuzzi S; Marrelli D; Roviello F; Volterrani L
Gastroenterol Res Pract; 2018; 2018():1794524. PubMed ID: 29736166
[TBL] [Abstract][Full Text] [Related]
2. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer).
Mazzei MA; Di Giacomo L; Bagnacci G; Nardone V; Gentili F; Lucii G; Tini P; Marrelli D; Morgagni P; Mura G; Baiocchi GL; Pittiani F; Volterrani L; Roviello F
Quant Imaging Med Surg; 2021 Jun; 11(6):2376-2387. PubMed ID: 34079708
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
[TBL] [Abstract][Full Text] [Related]
4. Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodes.
Tsekrekos A; Vieth M; Ndegwa N; Bateman A; Flejou JF; Grabsch HI; Mastracci L; Meijer SL; Saragoni L; Sheahan K; Shetye J; Yantiss R; Lundell L; Detlefsen S
Hum Pathol; 2021 Oct; 116():94-101. PubMed ID: 34284051
[TBL] [Abstract][Full Text] [Related]
5. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
[TBL] [Abstract][Full Text] [Related]
6. CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy.
Chen Y; Xu W; Li YL; Liu W; Sah BK; Wang L; Xu Z; Wels M; Zheng Y; Yan M; Zhang H; Ma Q; Zhu Z; Li C
Front Oncol; 2022; 12():758863. PubMed ID: 35280802
[TBL] [Abstract][Full Text] [Related]
7. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy.
Liu ZN; Wang YK; Zhang L; Jia YN; Fei S; Ying XJ; Zhang Y; Li SX; Sun Y; Li ZY; Ji JF
World J Gastrointest Oncol; 2021 Dec; 13(12):2161-2179. PubMed ID: 35070049
[TBL] [Abstract][Full Text] [Related]
8. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
9. Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
Shi Y; Chen Y; Li X; Wang Z; Sun Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):133-139. PubMed ID: 28270296
[TBL] [Abstract][Full Text] [Related]
10. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
[TBL] [Abstract][Full Text] [Related]
11. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?
Sun ZQ; Yan G; Ge YX; Li J; Jin LF; Xie ZH; Zhao P
J Xray Sci Technol; 2017; 25(6):981-991. PubMed ID: 28697579
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging.
Xu HD; Zhang YQ
Neoplasma; 2017; 64(3):430-436. PubMed ID: 28253722
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of visual residual tumour cells (VRTC) for patients with esophageal squamous cell carcinomas after neoadjuvant therapy followed by surgery.
Wang X; Wang H; Wang H; Huang J; Wang X; Jiang Z; Tan L; Jiang D; Hou Y
BMC Cancer; 2021 Feb; 21(1):111. PubMed ID: 33535987
[TBL] [Abstract][Full Text] [Related]
14. [Key points of perioperative whole-process management for patients with advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):115-122. PubMed ID: 32074789
[TBL] [Abstract][Full Text] [Related]
15. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy.
Serayssol C; Maulat C; Breibach F; Mokrane FZ; Selves J; Guimbaud R; Otal P; Suc B; Berard E; Muscari F
World J Gastrointest Oncol; 2019 Apr; 11(4):295-309. PubMed ID: 31040895
[TBL] [Abstract][Full Text] [Related]
17. Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience.
Morgagni P; Bencivenga M; Colciago E; Tringali D; Giacopuzzi S; Framarini M; Saragoni L; Mura G; Graziosi L; Marino E; Fumagalli Romario U; Baiocchi G; Moretti A; Rossi V; Verlato G
Clin Nucl Med; 2020 Mar; 45(3):177-181. PubMed ID: 31977470
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients With Locally Advanced Esophageal Cancer.
Baksh K; Prithviraj G; Kim Y; Hoffe S; Shridhar R; Coppola D; Centeno B; Pimiento J; Meredith K; Almhanna K
Am J Clin Oncol; 2018 Mar; 41(3):254-258. PubMed ID: 26703814
[TBL] [Abstract][Full Text] [Related]
20. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
